Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Sep 20 04:00PM ET
102.23
Dollar change
-1.01
Percentage change
-0.98
%
IndexS&P 500 P/E- EPS (ttm)-9.23 Insider Own9.98% Shs Outstand255.29M Perf Week-1.31%
Market Cap26.14B Forward P/E22.25 EPS next Y4.59 Insider Trans-0.01% Shs Float230.14M Perf Month1.98%
Income-2352.00M PEG- EPS next Q1.07 Inst Own84.13% Short Float1.18% Perf Quarter6.51%
Sales11.31B P/S2.31 EPS this Y26.18% Inst Trans-0.77% Short Ratio2.13 Perf Half Y22.70%
Book/sh55.75 P/B1.83 EPS next Y9.02% ROA-7.35% Short Interest2.71M Perf Year46.04%
Cash/sh2.62 P/C38.95 EPS next 5Y13.11% ROE-14.76% 52W Range62.28 - 105.30 Perf YTD26.26%
Dividend Est.1.67 (1.63%) P/FCF26.43 EPS past 5Y- ROI-10.02% 52W High-2.92% Beta1.23
Dividend TTM2.82 (2.76%) Quick Ratio1.75 Sales past 5Y31.28% Gross Margin28.47% 52W Low64.15% ATR (14)1.84
Dividend Ex-DateSep 20, 2024 Current Ratio2.38 EPS Y/Y TTM-8.14% Oper. Margin8.68% RSI (14)52.52 Volatility1.54% 1.72%
Employees21500 Debt/Eq0.71 Sales Y/Y TTM-4.65% Profit Margin-20.79% Recom2.21 Target Price104.70
Option/ShortYes / Yes LT Debt/Eq0.65 EPS Q/Q527.10% Payout- Rel Volume3.05 Prev Close103.24
Sales Surprise2.18% EPS Surprise16.65% Sales Q/Q-1.37% EarningsAug 06 AMC Avg Volume1.27M Price102.23
SMA20-0.49% SMA502.65% SMA20014.72% Trades Volume3,882,937 Change-0.98%
Date Action Analyst Rating Change Price Target Change
Sep-11-24Reiterated Oppenheimer Outperform $116 → $117
Sep-03-24Upgrade Mizuho Neutral → Outperform $109 → $120
Jul-22-24Upgrade Stifel Hold → Buy $95 → $115
Jun-07-24Initiated Oppenheimer Outperform $116
May-21-24Downgrade Morgan Stanley Overweight → Equal-Weight $100
May-08-24Upgrade JP Morgan Neutral → Overweight $75 → $100
Apr-18-24Upgrade Barclays Underweight → Equal Weight
Apr-10-24Upgrade Citigroup Neutral → Buy $81 → $100
Mar-08-24Downgrade Argus Buy → Hold
Mar-01-24Initiated Wolfe Research Underperform
Sep-16-24 09:50AM
Sep-08-24 03:04PM
Sep-07-24 07:53PM
Sep-06-24 12:00PM
Sep-05-24 11:31AM
06:23PM Loading…
Sep-02-24 06:23PM
Aug-30-24 06:09PM
Aug-27-24 06:07PM
Aug-15-24 04:15PM
Aug-12-24 09:15AM
Aug-08-24 01:16AM
Aug-07-24 04:26PM
02:11PM
Aug-06-24 06:30PM
05:25PM
04:25PM Loading…
04:25PM
04:15PM
Aug-05-24 09:04AM
Aug-01-24 09:15AM
Jul-30-24 09:00PM
05:08PM
12:19PM
10:01AM
Jul-09-24 04:15PM
Jun-30-24 09:12AM
Jun-28-24 09:50AM
Jun-26-24 04:00AM
Jun-24-24 06:35AM
Jun-12-24 09:50AM
Jun-05-24 11:30AM
04:15PM Loading…
May-30-24 04:15PM
04:15PM
May-29-24 04:15PM
May-27-24 06:00AM
May-21-24 12:30PM
12:22PM
May-15-24 09:00AM
May-14-24 04:01PM
May-13-24 08:59AM
May-10-24 09:27AM
May-09-24 06:43AM
May-08-24 03:30PM
11:18AM
11:11AM
08:34AM
08:05AM
07:36AM
07:00AM
06:52AM
06:52AM
06:52AM
05:44AM
03:21AM
01:06AM
May-07-24 11:13PM
04:48PM
12:47PM
12:42PM
10:29AM
07:43AM
07:39AM
May-06-24 06:12PM
06:00PM
05:55PM
05:30PM
04:58PM
04:38PM
04:16PM
04:15PM
May-03-24 08:42AM
May-02-24 09:00AM
May-01-24 04:15PM
12:15PM
09:15AM
Apr-29-24 10:00AM
09:00AM
Apr-16-24 04:15PM
Apr-03-24 01:07PM
12:47AM
12:00AM
Mar-28-24 01:38PM
Mar-25-24 08:00PM
Mar-21-24 06:45AM
Mar-20-24 01:59PM
07:04AM
Mar-19-24 12:21PM
06:59AM
06:52AM
06:45AM
Mar-13-24 07:43PM
Mar-11-24 01:01PM
Mar-04-24 03:00AM
Mar-01-24 04:15PM
Feb-29-24 04:15PM
12:01AM
Feb-28-24 08:06PM
07:00AM
Feb-22-24 10:01AM
05:40AM
Feb-21-24 11:14PM
International Flavors & Fragrances, Inc. engages in the manufacture and supply of flavors and fragrances used in the food, beverage, personal care, and household products industries. It operates through the following segments: Nourish, Health & Biosciences, Scent and Pharma Solutions. The Nourish segment consists of legacy Taste segment combined with N&B's Food & Beverage division and the food protection business of N&B's Health & Biosciences division. The Health & Biosciences business consists of a biotechnology-driven portfolio of enzymes, food cultures, probiotics and specialty ingredients for food, home and personal care, and health and wellness applications. The Scent business creates fragrance compounds, fragrance ingredients and cosmetic ingredients that are integral elements in the world's finest perfumes and best-known household and personal care products. The Pharma Solutions business produces a vast portfolio including cellulosics and seaweed-based pharma excipients, used to improve the functionality and delivery of active pharmaceutical ingredients, including controlled or modified drug release formulations, and enabling. The company was founded in 1833 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Borg DeborahEVP, Chief HR and D&I OfficerSep 03 '24Option Exercise0.0013,807030,282Sep 05 04:05 PM
Herriott SimonPres. Health & BioscienceJul 03 '24Option Exercise0.00627010,759Jul 05 04:10 PM
Strzelecki AngelaPresident, Pharma SolutionsJun 13 '24Option Exercise77.162,588199,69011,127Jun 14 04:56 PM
Strzelecki AngelaPresident, Pharma SolutionsJun 13 '24Sale95.662,588247,5608,539Jun 14 04:56 PM
Yildiz BerilCAO, SVP & ControllerMay 03 '24Option Exercise0.0084801,588May 07 07:06 PM
O'Byrne KevinDirectorMay 03 '24Option Exercise0.001,67101,933May 07 07:06 PM
Strzelecki AngelaPresident, Pharma SolutionsMay 03 '24Option Exercise0.001,06008,868May 07 07:06 PM
Teles de Mendonca Ana PaulaPresident, ScentMay 06 '24Option Exercise0.0072601,178May 07 07:06 PM
Teles de Mendonca Ana PaulaPresident, ScentMay 03 '24Option Exercise0.007070707May 07 07:06 PM
RICHTER GLENN RCFOMay 03 '24Option Exercise0.004,243021,889May 07 07:06 PM
Johnson Jennifer AmyEVP, General CounselMay 03 '24Option Exercise0.002,12107,936May 07 07:04 PM
Hu GaoxiangDirectorMay 03 '24Option Exercise0.001,67102,105May 07 07:04 PM
Herriott SimonPres. Health & BioscienceMay 03 '24Option Exercise0.001,591010,625May 07 07:03 PM
Gold Christina ADirectorMay 03 '24Option Exercise0.001,671010,840May 07 07:03 PM
Finzel RalfEVP, Global Operations OfficerMay 03 '24Option Exercise0.001,32604,770May 07 07:03 PM
Ferguson Roger W. Jr.DirectorMay 03 '24Option Exercise0.002,62502,625May 07 06:56 PM
DAVIDSON CAROL ANTHONYDirectorMay 03 '24Option Exercise0.001,67101,926May 07 06:56 PM
Costa Mark JDirectorMay 03 '24Option Exercise0.001,67102,139May 07 06:55 PM
Bruno Barry A.DirectorMay 03 '24Option Exercise0.001,67103,205May 07 06:55 PM
Borg DeborahEVP, Chief HR and D&I OfficerMay 03 '24Option Exercise0.001,768017,188May 07 06:55 PM
Arora YuvrajPresident, NourishMay 03 '24Option Exercise0.0011,538011,538May 07 06:54 PM
Johnson Jennifer AmyEVP, General CounselApr 05 '24Option Exercise0.0096806,165Apr 09 05:28 PM
Herriott SimonPres. Health & Biosci. & ScentApr 05 '24Option Exercise0.001,59009,496Apr 09 05:26 PM
Strzelecki AngelaPresident, Pharma SolutionsApr 05 '24Option Exercise0.001,14008,162Apr 09 05:25 PM
Herriott SimonPres. Health & Biosci. & ScentApr 01 '24Option Exercise0.001,48908,367Apr 03 04:24 PM
Clyburn FrankChief Executive OfficerMar 01 '24Option Exercise0.001,32402,170Mar 05 07:06 PM
Strzelecki AngelaPresident, Pharma SolutionsJan 03 '24Option Exercise0.001,34107,418Jan 04 04:06 PM
Finzel RalfEVP, Global Operations OfficerDec 01 '23Option Exercise0.005,38705,387Dec 04 04:17 PM
Johnson Jennifer AmyEVP, General CounselNov 01 '23Option Exercise0.001,04105,459Nov 03 04:12 PM
Yildiz BerilCAO, SVP & ControllerOct 03 '23Option Exercise0.001,07701,077Oct 05 04:09 PM
RICHTER GLENN RCFOOct 02 '23Option Exercise0.0011,812023,624Oct 04 04:08 PM